Retatrutide, a novel dual stimulator of the GLP-1 receptor and glucose-dependent insulinotropic polypeptide (GIP) target, is exhibiting promising outcomes in initial clinical trials . Ongoing research https://shopretatrutidepeptide.com/retatrutide-research-knowledge-hub/